-
Vaccine demonstrates significant efficacy against severe rotavirus
europeanpharmaceuticalreview
September 28, 2017
Results from a Phase 3 efficacy study in India of the rotavirus vaccine Rotasil showed the vaccine to be safe, against severe rotavirus gastroenteritis…
-
HPV vaccine associated with improved fertility
europeanpharmaceuticalreview
September 21, 2017
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception…
-
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
worldpharmanews
September 18, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
-
New method allows one vaccine injection carrying multi doses
europeanpharmaceuticalreview
September 18, 2017
Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered…
-
Newly adopted flu vaccine could save 1,700 lives
pharmafile
September 13, 2017
The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data has been released to back up this decision, showing that a potential 1,700 lives could be saved through its use.
-
Improved vaccine protects against nine types of HPV
europeanpharmaceuticalreview
September 08, 2017
Scientists have developed an improved vaccine commonly associated with cervical cancer…
-
Gavi to save 20M lives, $350B with vaccine program by 2020
fiercepharma
September 06, 2017
The good it’s doing will have amounted to 20 million lives, along with $350 billion healthcare costs, saved by 2020, a new study found.
-
New flu vaccine approved for UK use
pharmatimes
August 23, 2017
The Medicines and Healthcare products Regulatory Agency has cleared the adjuvanted trivalent influenza vaccine Fluad for use in people aged 65 years or older
-
"Indian manufacturers account for 60% of vaccine supplies made to UNICEF”
biospectrumasia
August 23, 2017
‘Indian vaccine manufacturers have several products in their R&D pipeline and as they roll out, the dominance of the multinational companies will subside in the coming years’,
-
ICMR, Department of Health and Family Welfare of MoH&FW sign MoU with IVI
expressbpd
August 22, 2017
The partnership will promote further collaborative research activities and training programs between India and IVI